Literature DB >> 6311092

Cefmenoxime penetration into gallbladder bile and tissue.

B R Smith, J LeFrock, B B Carr.   

Abstract

Cefmenoxime concentrations in gallbladder bile and tissue were assessed in patients undergoing cholecystectomy. A 0.5-g intravenous dose produced mean concentrations in bile of 54.1 micrograms/ml at 62.9 min and 56.3 micrograms/ml at 194 min after the dose was given. A 1.0-g intravenous dose produced concentrations in bile of 117.9 micrograms/ml at 53 min and 169.7 micrograms/ml of 194 min after the dose was given. Mean concentrations in tissue ranged from 6.1 to 17.9 micrograms/g. Biliary tree penetration was dose and time dependent. Therapeutic concentrations were achieved.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311092      PMCID: PMC185014          DOI: 10.1128/AAC.23.6.941

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Antibiotic treatment of biliary sepsis.

Authors:  M R Keighley; R B Drysdale; A H Quoraishi; D W Burdon; J Alexander-Williams
Journal:  Surg Clin North Am       Date:  1975-12       Impact factor: 2.741

2.  The bacteriology of the obstructed biliary tree.

Authors:  A C Maddocks; G R Hilson; R Taylor
Journal:  Ann R Coll Surg Engl       Date:  1973-05       Impact factor: 1.891

3.  Bacteria and biliary tract disease.

Authors:  J T Goswitz
Journal:  Am J Surg       Date:  1974-11       Impact factor: 2.565

4.  Gallbladder bacteriology, histology, and gallstones. Study of unselected cholecystectomy specimens in Honolulu.

Authors:  F H Fukunaga
Journal:  Arch Surg       Date:  1973-02

5.  Bacteriology of calculous cholecystitis.

Authors:  H Chaitin
Journal:  Int Surg       Date:  1973-03

6.  Bacteriology and antibiotic selection in biliary tract surgery.

Authors:  G R Mason
Journal:  Arch Surg       Date:  1968-10

7.  Biliary bacteremia.

Authors:  S H Chetlin; D W Elliott
Journal:  Arch Surg       Date:  1971-04

8.  Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria.

Authors:  P C Fuchs; R N Jones; C Thornsberry; A L Barry; E H Gerlach; H M Sommers
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

9.  In vitro activity and beta-lactamase stability of cefmenoxime.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

10.  Antimicrobial activity of cefmenoxime (SCE-1365).

Authors:  J M Stamm; R L Girolami; N L Shipkowitz; R R Bower
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

View more
  3 in total

Review 1.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

2.  Cefmenoxime pharmacokinetics in patients with renal insufficiency.

Authors:  R E Polk; D A Sica; T M Kerkering; B J Kline; P M Patterson; J W Baggett
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

3.  Antimicrobial activities of BMY-28142, cefbuperazone, and cefpiramide compared with those of other cephalosporins.

Authors:  N J Khan; J A Bihl; R F Schell; J L LeFrock; S J Weber
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.